- 米国企業
- CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc.CNSP
時価総額
$113.9万
PER
| 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| General and administrative | 2 | 4 | 5 | 6 |
| Research and development | 2 | 5 | 9 | 9 |
| Total operating expenses | 4 | 9 | 14 | 15 |
| Loss from operations | -3,832,977 | -9,454,607 | -14,027,293 | -15,267,107 |
| Interest expense | 26,152 | 3,264 | 9,285 | 7,027 |
| Total other expenses | -44,234 | -3,264 | -9,285 | -7,027 |
| Net loss | -3,877,211 | -9,457,871 | -14,036,578 | -15,274,134 |
| Loss per share - basic | - | - | - | -11.22 |
| Loss per share - diluted | - | - | - | -11.22 |